NEW YORK (GenomeWeb) – Microbial genetics analysis firm OpGen said in a regulatory document that it has raised more than $1.2 million toward a targeted $1.5 million private financing round. 

Through a spokesperson, the Gaithersburg, Md.-based firm declined to comment. OpGen said in a document filed with the US Securities and Exchange Commission that there were nine investors in the round, but did not identify them. It also did not say how the funds would be used. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.